PRODUCT INFORMATION
Description
The F3 peptide, a proteolytic fragment derived from human high-mobility group protein B2 (HMGB2), demonstrates tumor-selective targeting capabilities. It binds with high affinity to membrane-associated nucleolin, which is expressed on cancer cells and angiogenic vascular endothelium. This molecular interaction enables its use as a multifunctional ligand for researching targeted molecular delivery systems in vitro and in vivo models.
Molecular Weight
3433.02
Purity
> 95%
Formula
C₁₅₂H₂₆₃N₄₉O₄₁
Product Type
Targeting Peptide
Sequence
Lys-Asp-Glu-Pro-Gln-Arg-Arg-Ser-Ala-Arg-Leu-Ser-Ala-Lys-Pro-Ala-Pro-Pro-Lys-Pro-Glu-Pro-Lys-Pro-Lys-Lys-Ala-Pro-Ala-Lys-Lys
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- Cyclo(-RGDfK) TFA Targeting Peptide (CAT#: OLY-1025-YS-53)
- FFAGLDD TFA Targeting Peptide (CAT#: OLY-1025-YS-49)
- Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA Targeting Peptide (CAT#: OLY-1025-YS-51)
- Breast Cancer Targeting Peptide 18-4 (CAT#: OLY-1025-YS-23)
- Osteocalcin (1-49) (human) Targeting Peptide (CAT#: OLY-1025-YS-9)
- Cyclo(Arg-Gly-Asp-D-Phe-Cys) TFA Targeting Peptide (CAT#: OLY-1025-YS-68)
- Somatostatin-28 (1-14) Targeting Peptide (CAT#: OLY-1025-YS-60)
- PSMA Targeting Peptide (CAT#: OLY-1025-YS-8)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.